CIBC Private Wealth Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$158M Sell
762,539
-5,772
-0.8% -$1.14M 0.27% 98
2025
Q3
$142M Buy
768,311
+824
+0.1% +$141K 0.24% 106
2025
Q2
$117M Sell
767,487
-18,178
-2% -$2.79M 0.21% 117
2025
Q1
$118M Sell
785,665
-38,315
-5% -$5.99M 0.25% 98
2024
Q4
$117M Sell
823,980
-17,102
-2% -$2.65M 0.21% 107
2024
Q3
$136M Buy
841,082
+137,291
+20% +$21.9M 0.24% 98
2024
Q2
$102M Sell
703,791
-8,571
-1% -$1.27M 0.19% 119
2024
Q1
$112M Sell
712,362
-4,892
-0.7% -$779K 0.22% 111
2023
Q4
$112M Buy
717,254
+3,938
+0.6% +$604K 0.24% 103
2023
Q3
$111M Sell
713,316
-400,037
-36% -$66M 0.26% 94
2023
Q2
$184M Buy
1,113,353
+76,014
+7% +$12.3M 0.4% 68
2023
Q1
$76.2M Sell
1,037,339
-470,290
-31% -$75.9M 0.17% 132
2022
Q4
$119M Buy
1,507,629
+130,595
+9% +$22.5M 0.4% 69
2022
Q3
$225M Buy
1,377,034
+6,541
+0.5% +$1.11M 0.61% 51
2022
Q2
$243M Buy
1,370,493
+192,863
+16% +$34.4M 0.63% 46
2022
Q1
$209M Buy
1,177,630
+156,859
+15% +$26.7M 0.46% 63
2021
Q4
$175M Buy
1,020,771
+51,690
+5% +$8.46M 0.36% 78
2021
Q3
$157M Sell
969,081
-57,434
-6% -$9.8M 0.36% 74
2021
Q2
$169M Sell
1,026,515
-1,104,679
-52% -$183M 0.39% 73
2021
Q1
$350M Sell
2,131,194
-897,993
-30% -$145M 0.88% 25
2020
Q4
$477M Buy
3,029,187
+32,356
+1% +$4.77M 1.26% 13
2020
Q3
$446M Buy
2,996,831
+422,574
+16% +$62.5M 1.37% 11
2020
Q2
$362M Sell
2,574,257
-143,531
-5% -$20.9M 1.76% 8
2020
Q1
$356M Sell
2,717,788
-1,214
-0% -$172K 1.53% 7
2019
Q4
$397M Buy
2,719,002
+450,490
+20% +$61.1M 1.29% 11
2019
Q3
$294M Sell
2,268,512
-24,288
-1% -$3.2M 1.03% 22
2019
Q2
$319M Buy
2,292,800
+266,902
+13% +$36.9M 1.12% 15
2019
Q1
$283M Sell
2,025,898
-38,327
-2% -$5.13M 1.09% 13
2018
Q4
$266M Buy
2,064,225
+71,990
+4% +$10M 1.19% 12
2018
Q3
$275M Sell
1,992,235
-15,791
-0.8% -$2.1M 1.04% 15
2018
Q2
$244M Sell
2,008,026
-11,385
-0.6% -$1.42M 0.99% 16
2018
Q1
$259M Sell
2,019,411
-58,444
-3% -$7.9M 1.12% 13
2017
Q4
$290M Buy
2,077,855
+17,815
+0.9% +$2.48M 1.23% 11
2017
Q3
$268M Buy
2,060,040
+391,068
+23% +$51.8M 1.22% 10
2017
Q2
$221M Sell
1,668,972
-21,516
-1% -$2.74M 1.39% 11
2017
Q1
$211M Sell
1,690,488
-9,024
-0.5% -$1.08M 1.32% 14
2016
Q4
$196M Buy
1,699,512
+10,417
+0.6% +$1.2M 1.29% 15
2016
Q3
$200M Buy
1,689,095
+27,901
+2% +$3.38M 1.38% 9
2016
Q2
$202M Buy
1,661,194
+21,099
+1% +$2.4M 1.47% 10
2016
Q1
$177M Buy
1,640,095
+31,321
+2% +$3.24M 1.37% 12
2015
Q4
$165M Sell
1,608,774
-6,263
-0.4% -$630K 1.29% 13
2015
Q3
$151M Buy
1,615,037
+17,510
+1% +$1.69M 1.24% 16
2015
Q2
$156M Buy
1,597,527
+4,585
+0.3% +$459K 1.13% 15
2015
Q1
$160M Buy
1,592,942
+240,720
+18% +$24.5M 1.18% 12
2014
Q4
$141M Buy
1,352,222
+2,222
+0.2% +$234K 1.08% 22
2014
Q3
$144M Buy
1,350,000
+812
+0.1% +$84.2K 1.13% 16
2014
Q2
$141M Sell
1,349,188
-26,977
-2% -$2.73M 1.15% 13
2014
Q1
$135M Buy
+1,376,165
New +$128M 1.15% 14

Other funds holding JNJ

CIBC Private Wealth Group's JNJ Position: Q4 2025 in Review

CIBC Private Wealth Group reduced its Johnson & Johnson (JNJ) stake by 0.75% in Q4 2025, selling an estimated $1.14M and leaving 762,539 shares worth $158M. The position accounts for 0.27% of the portfolio, ranked #98.

CIBC Private Wealth Group first reported a position in JNJ in Q1 2014 and has held it in 48 quarters since. The position peaked at $477M in Q4 2020. 4,520 funds tracked by Wall St. Rank hold JNJ as of Q4 2025.

  • CIBC Private Wealth Group held 762,539 shares of Johnson & Johnson worth $158M as of Q4 2025.
  • CIBC Private Wealth Group sold 5,772 Johnson & Johnson shares in Q4 2025, an estimated $1.14M.
  • Johnson & Johnson made up 0.27% of CIBC Private Wealth Group's portfolio in Q4 2025, its #98 holding.
  • CIBC Private Wealth Group first reported a position in Johnson & Johnson in Q1 2014 and has held it in 48 quarters since.
  • CIBC Private Wealth Group's Johnson & Johnson position peaked at $477M in Q4 2020.
  • 4,520 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.